Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1993; 22:514-520
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antony, I
Right arrow Articles by Aptecar, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antony, I
Right arrow Articles by Aptecar, E

Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy

I Antony, A Nitenberg, JM Foult, and E Aptecar

Service d'Explorations Fonctionnelles, Institut National de la Sante de la Recherche Medicale Unite 251, Centre Hospitalier, Universitaire Xavier Bichat, Paris, France.

OBJECTIVES. This study was initiated to compare the coronary reserve in treated hypertensive patients with and without left ventricular hypertrophy with that in untreated patients. BACKGROUND. Coronary reserve is impaired in hypertensive patients with left ventricular hypertrophy and normal coronary arteries. Moreover, basal coronary resistance is elevated in hypertensive patients without left ventricular hypertrophy. METHODS. Coronary reserve was measured with a coronary Doppler catheter before and after a maximally vasodilating dose of intracoronary papaverine (peak/rest flow velocity ratio) in 16 control subjects and 37 hypertensive patients with normal epicardial coronary arteries. Among 20 untreated hypertensive patients, myocardial mass was increased in 11 (group 2a) and normal in 9 (group 2b). Seventeen patients had been treated effectively for at least 1 year; nine (group 3a) had persistent left ventricular hypertrophy, and eight (group 3b) had no left ventricular hypertrophy before treatment. Left ventricular volumes and ejection fraction were normal in all groups. RESULTS. Coronary reserve was moderately reduced in group 2b (3.5 +/- 0.6 vs. 5.2 +/- 0.8 in control subjects, p < 0.001) and markedly diminished in groups 2a and 3a (2.5 +/- 0.5 and 2.7 +/- 0.4, respectively; all p < 0.001 vs. control subjects). In group 3b, coronary reserve was comparable to that of control subjects (5.1 +/- 1.4). CONCLUSIONS. The reduction in coronary reserve observed in untreated hypertensive patients with normal myocardial mass suggests that structural abnormalities of the coronary microvasculature may occur before left ventricular hypertrophy. Treated patients with normal mass before treatment had a coronary reserve comparable to that of normotensive control subjects, whereas normalization of arterial pressure with persistent left ventricular hypertrophy was associated with a marked impairment of coronary reserve.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. J. Timmer, P. Knaapen, T. Germans, P. A. Dijkmans, M. Lubberink, J. M. ten Berg, F. J. ten Cate, I. K. Russel, M. J. W. Gotte, A. A. Lammertsma, et al.
Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy
Am J Physiol Heart Circ Physiol, July 1, 2011; 301(1): H129 - H137.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Koivuviita, R. Tertti, M. Jarvisalo, M. Pietila, J. Hannukainen, J. Sundell, P. Nuutila, J. Knuuti, and K. Metsarinne
Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2773 - 2779.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Erdogan, I. Yildirim, O. Ciftci, I. Ozer, M. Caliskan, H. Gullu, and H. Muderrisoglu
Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function
Circulation, February 6, 2007; 115(5): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema
Cross-talk between cardiac muscle and coronary vasculature.
Physiol Rev, October 1, 2006; 86(4): 1263 - 1308.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Erdogan, H Gullu, M Caliskan, I Yildirim, D Tok, and H Muderrisoglu
Coronary flow reserve is preserved in white-coat hypertension
Heart, August 1, 2006; 92(8): 1109 - 1112.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Kozakova, G. de Simone, C. Morizzo, and C. Palombo
Coronary Vasodilator Capacity and Hypertension-Induced Increase in Left Ventricular Mass
Hypertension, February 1, 2003; 41(2): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Bartel, Y. a Yang, S. Muller, R. R. Wenzel, D. Baumgart, T. Philipp, and R. Erbel
Noninvasive assessment of microvascular function in arterial hypertension by transthoracic doppler harmonic echocardiography
J. Am. Coll. Cardiol., June 19, 2002; 39(12): 2012 - 2018.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. R. Hildick-Smith and L. M. Shapiro
Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1889 - 1896.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Wieneke, M. Haude, J. Ge, C. Altmann, S. Kaiser, D. Baumgart, C. von Birgelen, D. Welge, and R. Erbel
Corrected coronary flow velocity reserve: a new concept for assessing coronary perfusion
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1713 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B Schwartzkopff and B.E Strauer
Squeezing tubes: a case of remodeling and regulation: Coronary reserve in hypertensive heart disease
Cardiovasc Res, October 1, 1998; 40(1): 4 - 8.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Laine, O. T. Raitakari, H. Niinikoski, O.-P. Pitkanen, H. Iida, J. Viikari, P. Nuutila, and J. Knuuti
Early impairment of coronary flow reserve in young men with borderline hypertension
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 147 - 153.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. C. McGill Jr, C. A. McMahan, R. E. Tracy, M. C. Oalmann, J. F. Cornhill, E. E. Herderick, and J. P. Strong
Relation of a Postmortem Renal Index of Hypertension to Atherosclerosis and Coronary Artery Size in Young Men and Women
Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1108 - 1118.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. M. Okin, M. J. Roman, J. E. Schwartz, T. G. Pickering, and R. B. Devereux
Relation of Exercise-Induced Myocardial Ischemia to Cardiac and Carotid Structure
Hypertension, December 1, 1997; 30(6): 1382 - 1388.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. L. Houghton, V. E. Smith, D. S. Strogatz, N. L. Henches, W. M. Breisblatt, and A. A. Carr
Effect of African-American Race and Hypertensive Left Ventricular Hypertrophy on Coronary Vascular Reactivity and Endothelial Function
Hypertension, March 1, 1997; 29(3): 706 - 714.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Kozakova, C. Palombo, L. Pratali, G. Pittella, F. Galetta, and A. L'Abbate
Mechanisms of Coronary Flow Reserve Impairment in Human Hypertension: An Integrated Approach by Transthoracic and Transesophageal Echocardiography
Hypertension, February 1, 1997; 29(2): 551 - 559.
[Abstract] [Full Text]


Home page
CirculationHome page
A. P. Burke, A. Farb, Y.-h. Liang, J. Smialek, and R. Virmani
Effect of Hypertension and Cardiac Hypertrophy on Coronary Artery Morphology in Sudden Cardiac Death
Circulation, December 15, 1996; 94(12): 3138 - 3145.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
E. D. Frohlich, D. Aristizabal, F. Soria, and F. H. Messerli
Investigative Concerns in Demonstrating Reduced Risk from Reversing Left Ventricular Hypertrophy
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1996; 1(1): 17 - 22.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement